Teams
Imagine's Offers
-
AnticoagulantsGenotype Phenotype
-
Observational trials
ENNOBLE-ATE (DU176b-C-U313) Edoxaban VS SOC, 7 patients
Sponsor DAIICHI SANKYO
CANNINES (B00661037) Apixaban
Sponsor Pfizer
TargetsTherapeuticsClinical trials -
-
Pulmonary hypertension in childrenGenotype Phenotype
-
Cohorts
Please, contact us
-
Observational trials
TOPP Registry: >90 pediatric patients enrolled
Sponsor Actelion
ZOHO Database : 427 patients
Sponsor M3C
ITINERAIR Registry : 52 patients enrolled
Sponsor Société Française de Cardiologie
CARREG (CARdiac congenital defects and REGulation genes) Registry: 4,398 patients
Sponsor ARCFA
-
Patient samples
Please, contact us
TargetsTherapeuticsClinical trials-
NCT
RUBATO (AC-055H301) Macitentan vs placebo Phase III
Sponsor ACTELION
RUBATO OL (AC-055H302)
Sponsor ACTELION
SALTO (AC-A065A310) Selexipag vs Placebo Phase III
Sponsor JANSSEN-CILAG
SELEXIPAG PEDIATRIC (AC-065A203) Selexipag
Sponsor ACTELION
TOMORROW Study Macitentan Phase III
Sponsor Actelion
-
-
Congenitally corrected transposition of great arteries (CCTGA)Genotype Phenotype
-
Cohorts
Please contact us
TargetsTherapeuticsClinical trialsAtrio Ventricular Canal Defect (AVCD)Genotype Phenotype-
Cohorts
Please contact us
Targets-
In vivo models
Nodal inactivation (conditional KO mouse model)
TherapeuticsClinical trialsDouble Outlet Right Ventricle (DORV)Genotype Phenotype-
Cohorts
Please contact us
Targets-
In vivo models
Nodal inactivation (conditional KO mouse model)
TherapeuticsClinical trialsTransposition of the great arteries (TGA)Genotype Phenotype-
Cohorts
Please contact us
Targets-
In vivo models
Nodal inactivation (conditional KO mouse model)
TherapeuticsClinical trialsCriss-cross heartGenotype Phenotype-
Cohorts
Please contact us
TargetsTherapeuticsClinical trials -
-
HeterotaxiaGenotype Phenotype
-
Cohorts
Please contact us
Targets-
In vivo models
Ift20 inactivation (KO & conditional KO mouse models)
Nodal inactivation (conditional KO mouse model)
TherapeuticsClinical trialsSitus inversusGenotype Phenotype-
Cohorts
Please contact us
TargetsTherapeuticsClinical trials -
-
Heart failure in childrenGenotype Phenotype
-
Cohorts
Please, contact us
-
Patient samples
Please, contact us
Targets-
In vivo models
Fat4 inactivation (conditional KO)
-
Specific targets
Fat4, Amotl1
TherapeuticsClinical trials-
NCT
PANORAMA (CLCZ696B2319) - LCZ (Entresto) VS Enalapril - Phase III pediatric patients
Sponsor Novartis
PANORAMA EXT (CLCZ696B2319E1)
Sponsor Novartis
-
-
Other cardiac congenital defectsGenotype Phenotype
-
Cohorts
Please, contact us
-
Observational trials
PREMICLOSE Registry: Transcatheter closure of PDA in preterm babies, 70 patients
Sponsor M3C, Necker Enfants-Malades hospital
MELODY Registry: Transcatheter pulmonary valve implantation, 45 patients
Sponsor Medtronic
Fetal aortic stenosis Registry: 15 patients
Sponsor M3C
FRANCISCO Registry: Observatoire Français des Communications Interventriculaires Congénitales avec hyperdébit pulmonaire
Sponsor Société Française de Cardiologie
CARREG (CARdiac congenital defects and REGulation genes) Registry: 4,398 patients
Sponsor ARCFA
BISMUTH Registry: Kawasaki disease, 93 patients
Sponsor Inserm
DCPT-FOIE Registry: Monitoring of liver functions in patients after Fontan operation, 26 patients
Sponsor M3C
-
Patient samples
Please, contact us
TargetsTherapeuticsClinical trials-
NCT
QUALI-REHAB study: cardiac rehabilitation program for teenagers and young adults with congenital heart disease, 4 patients
Sponsor Novartis
-
Contacts
-
Nicolas DOULET
Business development manager
- nicolas.doulet@institutimagine.org
- +33 1 42 75 42 55